Next Generation News and Research

RSS

New, cross-sector collaboration aims to discover clinical biomarker for pancreatic cancer

The search to discover and validate the first-ever clinical biomarker to diagnose and treat pancreatic cancer is at the foundation of a new, cross-sector collaboration. Berg, a biopharmaceutical company committed to uncovering health solutions through a data-driven, biological research approach; the Cancer Center at Beth Israel Deaconess Medical Center, a Harvard Medical School teaching hospital, and the Pancreatic Cancer Research Team managed by Cancer Research And Biostatistics announced today they will work together to eradicate the disease.

9 Apr 2015

Liaison Technologies announces availability of Liaison Alloy Health Platform

Liaison Technologies, an industry-recognized leader in cloud-based integration and data management offerings, today announced the availability of the Liaison Alloy Health Platform, a next-generation platform for integrating and managing data across the increasingly interdependent domains of healthcare, health research, and life sciences.

9 Apr 2015

UTMB scientists develop quick-acting vaccine that is effective against Ebola strain

An interdisciplinary team from The University of Texas Medical Branch at Galveston and Profectus BioSciences, Inc. has developed a quick-acting vaccine that is both safe and effective with a single dose against the Ebola strain that killed thousands of people in West Africa last year.

8 Apr 2015

PAREXEL announces three new academic programs to develop global biopharmaceutical workforce

PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced three new academic programs at the PAREXEL Academy.

From Parexel 8 Apr 2015

U-M's Taubman Institute receives $3 million gift to support next generation of medical research

A $3 million gift from noted business and philanthropic leaders Leslie and Abigail Wexner will support the next generation of medical research trailblazers at the University of Michigan through grants from the A. Alfred Taubman Medical Research Institute.

6 Apr 2015

eRelevance’s progressive patient engagement service sold to 100 Medspa, Plastic Surgery practices

eRelevance Corporation, announced today that its progressive patient engagement service has been sold to nearly 100 Medical Spa (Medspa) and Plastic Surgery practices in just the first quarter of 2015.

3 Apr 2015

Research may point to new paradigms in diagnosis, treatment of aggressive cancers

All living things--from dandelions to reindeer--evolve over time. Cancer cells are no exception, and are subject to the two overarching mechanisms described by Charles Darwin: chance mutation and natural selection.

3 Apr 2015

Registration opens for inaugural Stanford Medicine X|ED conference

Registration opened today for the inaugural Stanford Medicine X|ED conference, which will explore the role of technology and networked intelligence in shaping the future of medical education.

2 Apr 2015

BME announces launch of Speed Titan Nitinol Bone Fixation Implant

BioMedical Enterprises announced the launch of the Speed Titan Nitinol Bone Fixation Implant today. As the newest addition to the BME Speed Fixation System, the Speed Titan joins the BME Speed, Speed Arc and Speed Shift™ implants to create the world's most comprehensive family of continuous active compression Nitinol implants.

1 Apr 2015

Research reveals stark variation in genetic tests for inherited eye disease in England

New research from The University of Manchester published in the Journal of Community Genetics reveals a stark variation in genetic testing services for inherited eye disease in England.

31 Mar 2015

Study shows stark variation in genetic testing services for inherited eye conditions in England

New research from The University of Manchester published in the Journal of Community Genetics reveals a stark variation in genetic testing services for inherited eye disease in England.

31 Mar 2015

Genetic markers may predict tumor samples that respond to treatment

Patients with chronic myelomonocytic leukemia have limited treatment options, and those that exist are effective only in fewer than half of patients. Now, a new study identifies a panel of genetic markers that predicted which tumor samples would likely respond to treatment.

31 Mar 2015

USC Hospitalist Leadership Fellowship Program launched at ApolloMed

Apollo Medical Holdings, Inc., an integrated physician-centric healthcare delivery company, and the Keck School of Medicine of the University of Southern California (USC) Internal Medicine Residency Program today announced the launch of the USC Hospitalist Leadership Fellowship Program at ApolloMed.

30 Mar 2015

UAB scientist explores the bone development function of runx2 gene

Amjad Javed, Ph.D., of the University of Alabama at Birmingham, has taken a major step forward in understanding the bone development function of a gene called runx2, which could lead to future ways to speed bone healing, aid bone bioengineering, stem osteoporosis and reduce arthritis.

30 Mar 2015

3D respiratory tissue model shown to be effective for measuring impact of chemicals

A 3-dimensional model of human respiratory tissue has been shown to be an effective platform for measuring the impact of chemicals, like those found in cigarette smoke, or other aerosols on the lung.

27 Mar 2015

apceth begins Agenmestencel-T Phase II clinical trial in gastrointestinal cancer patients

apceth, a global leader in engineered cell therapies, today announced the successful completion of the Phase I and initiation of the Phase II part of its ongoing monocentric Phase I/II clinical trial TREAT-ME 1 with the engineered cell therapeutic product Agenmestencel-T, at the Klinikum Grosshadern in Munich.

27 Mar 2015

LifeCodexx announces promising results from proof-of-principle study of qPCR-based NIPT assay

LifeCodexx AG today reports the successful outcome of a proof-of-principle of its novel assay for non-invasive prenatal testing (NIPT assay) based on quantitative real-time PCR (qPCR). This NIPT assay, designed to determine fetal aneuploidies from maternal blood, will offer significant advantages, such as enhanced test performance at affordable prices, over other prenatal examination methods.

27 Mar 2015

Inergetics announces launch of branded CBD-based nutritional supplement

Inergetics,Inc., a world-class developer of NSF Certified nutritional and consumer health products, announced today the launch of Nulief, a branded nutritional supplement offering the holistic benefits associated with Cannabidiol (CBD).

26 Mar 2015

Vermillion announces total revenue of $1.6 million for fourth quarter 2014

Vermillion, Inc., a bio-analytical solutions company focused on gynecologic disease, reported on its results for the fourth quarter ended and full year ended December 31, 2014.

From Quest Diagnostics 25 Mar 2015

Association for Molecular Pathology submits written comments to FDA on NGS regulation

The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, submitted written comments on March 20 to the U.S. Food and Drug Administration (FDA) in response to the agency's request for feedback in association with its February 20, 2015 public workshop entitled, "Optimizing FDA's Regulatory Oversight of Next Generation Sequencing Diagnostic Tests."

24 Mar 2015

Next Generation News and Research

New, cross-sector collaboration aims to discover clinical biomarker for pancreatic cancer

Liaison Technologies announces availability of Liaison Alloy Health Platform

UTMB scientists develop quick-acting vaccine that is effective against Ebola strain

PAREXEL announces three new academic programs to develop global biopharmaceutical workforce

U-M's Taubman Institute receives $3 million gift to support next generation of medical research

eRelevance’s progressive patient engagement service sold to 100 Medspa, Plastic Surgery practices

Research may point to new paradigms in diagnosis, treatment of aggressive cancers

Registration opens for inaugural Stanford Medicine X|ED conference

BME announces launch of Speed Titan Nitinol Bone Fixation Implant

Research reveals stark variation in genetic tests for inherited eye disease in England

Study shows stark variation in genetic testing services for inherited eye conditions in England

Genetic markers may predict tumor samples that respond to treatment

USC Hospitalist Leadership Fellowship Program launched at ApolloMed

UAB scientist explores the bone development function of runx2 gene

3D respiratory tissue model shown to be effective for measuring impact of chemicals

apceth begins Agenmestencel-T Phase II clinical trial in gastrointestinal cancer patients

LifeCodexx announces promising results from proof-of-principle study of qPCR-based NIPT assay

Inergetics announces launch of branded CBD-based nutritional supplement

Vermillion announces total revenue of $1.6 million for fourth quarter 2014

Association for Molecular Pathology submits written comments to FDA on NGS regulation

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News